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A B S T R A C T   
The great diversity of marine habitats and organisms renders them a high-value source to find/develop novel 
drugs and formulations. Therefore, herein, sardine (Sardina pilchardus) roe was used as a lipidic source to pro-
duce liposomes. This fish product presents high nutritional value, being its lipidic content associated with 
important health benefits. Consequently, it can be advantageously used to produce therapeutically active de-
livery devices. Roe lipids were extracted using the Matyash method. After lipid film hydration and extrusion, 
sardine roe-derived large unilamellar liposomes (LUVs), designated as fishroesomes, presented a size of ≈330 nm 
and a significant negative surface charge (≈− 27 mV). Radical scavenging assays demonstrated that fishroesomes 
efficiently neutralized peroxyl, hydroxyl and nitric oxide radicals. Moreover, fishroesomes significantly reduced 
the expression of pro-inflammatory cytokines and chemokines by LPS-stimulated macrophages at non-toxic 
concentrations for L929 and THP-1 cells. Consequently, the developed liposomes exhibit unique properties as 
bioactive drug carriers for inflammatory diseases treatment.   
1. Introduction 
Marine products are a well-recognized source of pharmaceuticals, 
nutritional supplements and cosmetic additives [1]. Particularly in 
inflammation, marine compounds are considered valid alternatives to 
aid or to treat inflammatory disorders. Fish, for instance, contains an-
tioxidants and anti-inflammatory compounds. Its antioxidants include 
enzymes (superoxide dismutase, catalase, glutathione peroxidase and 
glutathione S-transferase), amino acids, peptides, reduced glutathione, 
gadusol, ascorbic acid, carotenoids, tocopherols, lipoic acid and ubi-
quinones [2–4]. Compounds with anti-inflammatory action include fatty 
acids, proteins and polysaccharides [5]. In fish, antioxidant and 
immune-relevant activities have also been described for vitellogenin, a 
glycolipophosphoprotein, and its derived yolk proteins, lipovitellin and 
phosvitin [6]. Consequently, fish can be advantageously used for the 
development of novel nutraceuticals. Indeed, the search of novel and 
natural compounds with biological activity has been extensively 
performed. 
Oxidative stress and inflammation are closely interrelated and have a 
major impact on the development of several and serious inflammatory 
diseases (e.g., autoimmune diseases). Oxidative stress results from the 
imbalance between the formation and neutralization of reactive oxygen 
species (ROS) and reactive nitrogen species (RNS) by endogenous anti-
oxidants, resulting in an excessive accumulation of these species [7]. 
ROS include peroxyl radicals (ROO•), hydroxyl radicals (•OH), super-
oxide anion radicals (O2•-), singlet oxygen, alkoxyl radical, hydrogen 
peroxide and lipid hydroperoxide, whereas RNS comprise nitric oxide 
(NO•), and species derived from NO•, such as peroxynitrite [4]. The 
production of ROS begins with the uptake of oxygen, activation of 
NADPH oxidase, and the production of O2•-. This reactive species is then 
converted to hydrogen peroxide and oxygen, which can interact with 
iron chelates to produce the highly reactive •OH. Conversely, ROO• is 
formed during oxidative damage of lipids, proteins, DNA and carbohy-
drates [8]. NO• is continuously produced in large amounts by the 
enzyme nitric oxide synthase. The reaction of NO• with O2•- produces 
peroxynitrite, a very potent oxidant. These radicals can react immedi-
ately and virtually with all biomolecules of vital cellular components 
and lead to the onset of the inflammation signalling. Inflammation is a 
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complex process and a necessary protective response of the immune 
system against a noxious stimulus, such as pathogens or damaged cells. 
However, when inflammation is excessive, it can lead to numerous 
pathological conditions [9]. Several chemical mediators regulate this 
process, including cytokines (e.g., interleukins – IL-1, IL-6 –, tumour 
necrosis factor – TNF-α), chemokines (e.g., CCL2, CCL5, CXCL8), lipid 
mediators (eicosanoids and platelet-activating factors), and reactive 
species that are generated by inflammatory cells [10,11]. Consequently, 
antioxidants and anti-inflammatory agents are critical to treat chronic 
inflammation. 
Groups of antioxidants and anti-inflammatory agents already avail-
able in the clinic or under development include, for instance, vitamins, 
scavenging compounds and food supplements (e.g., flavonoids) for the 
former set of compounds [7], whereas the latter group comprises 
nonsteroidal anti-inflammatory drugs (NSAIDs), glucocorticoids, anti-
cytokine therapies, small molecules that block the activity of kinases, 
resolvins, statins, and small RNAs, for instance [12]. However, some of 
these therapeutic agents present serious side effects and, consequently, 
there is still a need for new anti-inflammatory agents with minimal 
organ toxicity or for new approaches to limit their effect at the diseased 
tissue. Indeed, nanoparticles can be the solution to increase the thera-
peutic index of drugs with recognized and strong anti-inflammatory 
activity. 
Considering the beneficial effects of fish, this work explores sardine 
(Sardina pilchardus) roe as a source to produce novel liposomes – fish-
roesomes - with improved properties as carriers for drug delivery. In 
fact, it has been reported that sardine consumption reduces oxidative 
and inflammatory conditions [13] and it has beneficial effects in car-
diovascular diseases [14]. Moreover, benefits related to attenuated 
hyperglycaemia, improved insulin sensitivity and reversed cholesterol 
transport in type 2 diabetic rats were also described [15]. As sardine, its 
roe also presents high nutritional value. Indeed, it is an excellent source 
of ω3 polyunsaturated fatty acids (PUFAs), as recently demonstrated by 
gas chromatography/mass spectrometry (GC/MS) analyses [16], as well 
as essential amino acids (e.g., taurine and histidine) and B vitamins 
(unpublished work). Despite multilamellar liposomes (MLVs) value in 
particular applications [16], the most commonly used type of liposomes 
is large unilamellar liposomes (LUVs; formed by a single phospholipid 
bilayer and a large aqueous core, with a size higher than 50 or 100 nm, 
depending on the author [17]) due to their advantages, including higher 
homogeneity and lower size than MLVs. Indeed, these lipid-based 
nanovesicles are currently in the market [18]. Therefore, the present 
work aims to develop and characterize fishroesomes with antioxidant 
and anti-inflammatory properties. To produce fishroesomes, roe lipidic 
extracts were obtained using a green approach, namely the Matyash or 
methyl-tert-butyl ether (MTBE) method [19]. They were characterized 
in terms of size distribution, surface potential, stability and morphology. 
Their cytocompatibility was evaluated using L929 cells and THP-1 cells 
stimulated or not with lipopolysaccharides (LPS). L929, a mouse lung 
fibroblast cell line, is widely used for the early cytocompatibility eval-
uation of biomaterials [20]. THP-1 is a human monocytic cell line 
commonly used as a cellular model of inflammation, after its stimulation 
with LPS [21]. The antioxidant activity of the developed liposomes was 
assessed in vitro against different ROS (ROO•, •OH and O2•-) and RNS 
(NO•), using protocols well established in the literature [22–25]. 
Moreover, the anti-inflammatory activity of the produced liposomes was 
evaluated by quantifying the amount of pro-inflammatory cytokines 
(IL-6, IL-1β, TNF-α and IL-23) and chemokines (CCL2) produced by the 
LPS-stimulated macrophages. 
2. Materials and methods 
2.1. Materials 
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) was supplied 
by Avanti Polar Lipids, Inc., Alabaster, AL, USA. 2,2′-azobis(2- 
amidinopropane) dihydrochloride (AAPH), β-Nicotinamide adenine 
dinucleotide, reduced disodium salt hydrate (NADH), ammonium iron 
(II) sulfate, dexamethasone, Dulbecco’s modified Eagle’s medium 
(DMEM), ethylenediaminetetraacetic acid disodium salt dihydrate 
(EDTA), fluorescein sodium salt, gallic acid, L-α-phosphatidylcholine 
from egg yolk, L-Ascorbic acid, LPS from Escherichia coli O26:B6, mag-
nesium sulfate, N-(1-Naphthyl)ethylenediamine dihydrochloride (NED), 
N,N,N-Trimethyl-4-(6-phenyl-1,3,5-hexatrien-1-yl)phenylammonium 
p-toluenesulfonate (TMA-DPH), nitrotetrazolium blue chloride (NBT), 
phenazine methosulfate (PMS), phorbol 12-myristate 13-acetate (PMA), 
phosphate buffer saline (PBS), phosphoric acid, sodium bicarbonate, 
sodium nitroprusside (SNP) dihydrate, sulfanilamide (SA), tert-butyl 
methyl ether, trolox were obtained from Sigma-aldrich, Saint Louis, MO, 
USA. Antibiotic-Antimycotic, fetal bovine serum (FBS), Roswell Park 
Memorial Institute (RPMI) 1640 Medium and quant-iT™ Pico Green® 
dsDNA Assay Kit were acquired from Life Technologies, Paisley, United 
Kingdom. Celecoxib was obtained from abcr GmbH, Karlsruhe, Ger-
many. CellTiter 96® AQueous One Solution Cell Proliferation Assay was 
supplied by Promega, Madison, USA. Dimethyl sulfoxide (DMSO) was 
acquired from AMRESCO, Solon, USA. Ethanol and methanol were ac-
quired from Fisher Chemical, Loughborough, Leicestershire. Glacial 
acetic acid was supplied by VWR International LLC, Radnor, USA. 
Hydrogen peroxide 30% (w/w) was obtained from Panreac Química, 
Castellar del Vallès, Barcelona, Spain. LabAssay™ Phospholipid was 
supplied by Wako, Osaka, Japan. Micro BCA™ Protein Assay kit was 
acquired from Thermo Fisher Scientific, Kalamazoo, MI. 
2.2. Roe lipids extraction 
Roes of sardine (Sardina pilchardus), captured at the Portuguese 
mainland coast, were kindly donated by a local fisherman in October 
2017. Samples were weighed, freeze-dried (LyoQuest Plus ECO, Telstar) 
and stored at − 20 ºC until lipids extraction. 
Lipids from sardine roe were extracted using the Matyash or methyl- 
tert-butyl ether (MTBE) method, as previously described [16,19]. 
Briefly, 3 g of a freeze-dried roe sample was homogenized using an Ultra 
Turrax (T18 Basic, IKA) for 2 min with 120 mL of ice-cold 75% meth-
anol. 300 mL of tert-butyl methyl ether was then added, and the resulting 
homogenized was shaken for 1 h at room temperature (RT). Then, 75 mL 
of water was added and 10 min later, the solution was centrifuged 
(5810R, Eppendorf) at 12,000 g for 15 min, at 4 ºC. The organic phase 
was collected, dehydrated with magnesium sulfate and then dried under 
vacuum (RE-301, Stuart) or under a stream of nitrogen to obtain a lipid 
film. 
2.3. LUVs production 
The dried lipid film was hydrated with PBS and strongly vortexed to 
produce MLVs. Then, the MLVs suspension was extruded (Avanti Mini 
Extruder, Avanti Polar Lipids, Inc) through polycarbonate membranes of 
400 and 100 nm of pore size, 43 times, resulting in a LUVs suspension. 
This procedure was performed at 37 ºC. 
Liposomes composed of 1,2-dipalmitoyl-sn-glycero-3-phosphocho-
line (DPPC) or of egg yolk phosphatidylcholine (EPC) were also pro-
duced and used as controls. 4 mM DPPC and 4 mM EPC solutions, both in 
ethanol, were used to obtain liposomes as described above but, instead 
of 43, it was performed 21 passages through the polycarbonate mem-
branes. DPPC and EPC MLVs and subsequent LUVs preparation were 
also carried out above the respective phase transition temperature (45 ºC 
and RT, respectively). 
To evaluate the antioxidant activity of the produced liposomes, an 
appropriate amount of the fluorescent probe, namely TMA-DPH, was 
added to LUVs suspension in a 35:1 lipid to probe ratio. 
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2.4. LUVs characterization 
2.4.1. Phosphatidylcholine quantification 
The phosphatidylcholine (PC) concentration of LUVs was deter-
mined by LabAssay™ Phospholipid, following the recommendations of 
the manufacturer. Briefly, 2 μL of sample or standard solution and 300 
μL of colour reagent were mixed and incubated at 37 ºC for 5 min. The 
absorbance at 600 nm was measured using a microplate reader (Synergy 
HT, BioTek). PC concentration for each sample was calculated using a 
standard curve of concentration (ranging from 0 to 596.1 mg/dL) versus 
absorbance. As phosphatidylcholine is the predominant phospholipid in 
fish eggs [26], its content was generally referenced as the fishroesomes 
concentration. Additionally, it was recently demonstrated that this 
phospholipid accounted for about 87.6% of the total phospholipids in 
the MTBE extracts [16]. 
2.4.2. Size distribution and zeta potential 
The size and polydispersity index (PDI) of the LUVs suspension were 
evaluated by dynamic light scattering (DLS), and the zeta potential was 
determined by laser Doppler micro-electrophoresis using a zetasizer 
(Nano ZS, Malvern Instruments Ltd). The measurements were performed 
at 37 ºC and the liposomes concentration was 500 µM. 
2.4.3. LUVs stability 
The storage stability of the LUVs, kept at 4 ºC and under static con-
ditions, was assessed for one month through the regular determination 
of their size, PDI and zeta potential, as just described. 
2.4.4. LUVs morphology 
The morphology of the produced liposomes was assessed by scanning 
transmission electron microscopy (STEM) using a high-resolution field 
emission scanning electron microscope (Auriga Compact, Zeiss). LUVs 
concentration (PC content) was adjusted to 10 µM and the suspension 
was disposed into the surface of a support film of carbon (type-B 400 
mesh Cu). Microscope observation was carried out at 25 kV. 
2.5. In vitro antioxidant activity 
The LUVs scavenging activity against ROO• and •OH was assessed by 
measuring over time the fluorescence of two probes with different sol-
ubilities, namely fluorescein (hydrophilic) and TMA-DPH (amphiphilic), 
as described elsewhere [23]. Both probes lose their fluorescence when 
oxidized by ROO• or •OH. 
In the fluorescein assays, the decay on the fluorescence intensity was 
monitored at excitation and emission wavelengths of 485 ± 20 nm and 
528 ± 20 nm, respectively. For TMA-DPH, the fluorescence was recor-
ded at excitation and emission wavelengths of 355 ± 20 nm and 460 ±
20 nm, respectively. Fluorescence measurements were performed using 
a microplate reader (Synergy HT, BioTek), at 37 ºC, for 180 or 30 min for 
ROO• or •OH scavenging assays, respectively. Blank was only composed 
of the radical initiator and fluorescent probe (without the evaluated 
compounds). Additionally, to guarantee the stability of the probes in the 
presence of the different tested compounds, the following controls were 
made and compared: probes with the antioxidant and without the 
initiator, and probes in the buffer (without neither antioxidant nor 
initiator). As the fluorescence of the probes was similar in both cases 
throughout the experiment, it was possible to conclude that the tested 
compounds do not interfere with the probe behaviour. 
2.5.1. ROO• scavenging assay 
ROO• were generated in the aqueous phase by the thermo- 
decomposition of AAPH, at 37 ºC. 
For fluorescein assays, the reaction mixture contained the following 
final concentrations of reactants: 48 nM fluorescein, 15 mM AAPH and 
different concentrations of liposomes (0, 0.5, 1.0, 2.5, 5.0, 12.5, 25.0 
and 50.0 µM) or trolox (used as reference antioxidant; 0, 2.5, 5.0, 10.0, 
15.0 and 20.0 µM). APPH solution was added immediately before 
starting the measurements. Data were converted to relative fluorescence 
values by dividing the fluorescence intensity at a given time by the 
fluorescence intensity at 0 min. The ROO• scavenger efficiency was 
determined using Eq. (1): 
AUCevaluated compound − AUCblank
AUCblank
× 100 (1)  
where AUC is the area under the curve obtained for the fluorescence 
intensity decay in the presence or absence (blank) of the evaluated 
compounds. The resulting data were plotted versus the concentration of 
the tested compounds in order to obtain the profile of their ROO•
scavenging activity. Moreover, the scavenger efficiency of the tested 
LUVs against ROO• was expressed as IC50 values, which were calculated 
as the concentration of each compound required to obtain 50% in the Eq. 
(1). 
In TMA-DPH experiments, the final mixture contained: 15 mM 
AAPH, and different concentrations of LUVs incorporating the amphi-
philic probe in a ratio of 35:1 (0.05, 0.10, 0.18, 0.25, 0.50 and 
1.00 mM). 
2.5.2. •OH scavenging assay 
•OH were generated by Fenton reaction [23]. Fe2+-EDTA solution 
was added to the samples, followed by the addition of the hydrogen 
peroxide solution. 
For fluorescein assays, the reaction mixture contained the following 
final concentrations of reactants: 48 nM fluorescein, 1 mM Fe2+-EDTA 
(1:1.1), 4 mM hydrogen peroxide and different concentrations of lipo-
somes (0, 0.5, 1.0, 2.5, 5.0, 12.5, 25.0 and 50.0 µM) or trolox (0, 2.5, 5.0, 
10.0, 15.0 and 20.0 µM). The scavenger efficiency of the tested com-
pounds in the presence of •OH was expressed as previously referred. 
For TMA-DPH assays, the final mixture contained: 1 mM Fe2+-EDTA 
(1:1.1), 4 mM hydrogen peroxide and different concentrations of LUVs 
with TMA-DPH in a ratio of 35:1 (0.05, 0.10, 0.18, 0.25, 0.50 and 
1.00 mM). 
2.5.3. NO• scavenging assay 
SNP spontaneously produces NO• at physiological pH. Then, NO•
interacts with oxygen to produce nitrite ions that can be detected by the 
Griess reagent. The detection involves the deionization of SA, in an 
acidic medium, to a diazonium salt, which couples with NED to produce 
a purple product. The experiment was adapted from that described by 
Pardau and collaborators [24]. The reaction mixture contained 8 mM 
SNP and different concentrations of liposomes (0, 5.0, 12.5, 25.0, 50.0, 
100.0, 200.0 µM) or gallic acid (used as reference antioxidant; 0, 1.0, 
2.0, 5.0, 10.0, 15.0, 20.0, 30.0, 40.0 and 50.0 µM). After incubation of 
these mixtures for 15 min at 37 ºC and under light [25], 1% SA in 20% 
glacial acetic acid was added. 10 min later and addition of 0.1% NED in 
2.5% phosphoric acid, the absorbance at 540 nm was measured in a 
microplate reader (Synergy HT, BioTek). 
The scavenger efficiency of the tested compounds against NO• was 
calculated using the Eq. (2): 
Ablank − Atested compound
Ablank
× 100 (2)  
where A is the absorbance in the presence or absence (blank) of the 
evaluated compounds. The resulting data were also plotted against the 
concentration of the compounds. Additionally, the NO• scavenging ac-
tivity was expressed as IC25 values, which were determined as the 
concentration of each tested compound required to obtain 25% in the 
Eq. (2). 
2.5.4. O2•- scavenging assay 
O2•- were generated in the NADH/PMS mixture, in the presence of 
dissolved oxygen. Then, these radicals reduce NBT to a purple formazan 
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[25]. The reaction mixture contained the following reagents at the 
indicated final concentrations: 166 μM NADH, 43 μM NBT, 2.7 μM PMS, 
different concentrations of liposomes (0, 5.0, 12.5, 25.0, 50.0, 100.0, 
200.0 µM) or ascorbic acid (used as reference antioxidant; 0, 10.0, 20.0, 
40.0, 80.0 and 160.0 µM). After incubation for 2 min at RT, the absor-
bance at 560 nm was measured in a microplate reader (Synergy HT, 
BioTek). The inhibition of the O2•- production in percentage was deter-
mined using Eq. (2). 
2.6. Biological assays 
2.6.1. Cell culture and seeding 
A mouse fibroblast cell line, L929, was cultured in DMEM, supple-
mented with 10% FBS and 1% antibiotic/antimycotic solution (100 U/ 
mL penicillin and 100 mg/mL streptomycin), and incubated at 37 ◦C in a 
humidified 5% CO2 atmosphere. For the assessment of the biological 
effects of fishroesomes, cells were seeded on 24-well plates at a density 
of 1 × 105 cells. L929 cells were used between passage number 19 and 
23. Different concentrations of liposomes (0, 0.06, 0.12, 0.25, 0.50 and 
1.00 mM) were added to the cell cultures 24 h later. LUVs were steril-
ized by filtration through membranes of 0.2 µm pore size. 10% DMSO in 
culture medium was used as the positive control for cell death. Cells 
were collected after 24, 48 and 72 h of incubation. 
Human monocytic cell line, THP-1, was obtained from American 
Type Culture Collection (ATCC® TIB-202™). These cells, at passage 
number 11–15, were maintained in RPMI 1640 medium with 2 mM 
glutamine, 25 mM HEPES, 1% antibiotic/antimycotic solution (100 U/ 
mL penicillin and 100 mg/mL streptomycin) and 10% FBS (complete 
RPMI), and incubated at 37 ºC with 5% CO2 in air atmosphere. THP-1 
cells differentiation into macrophages was performed as described 
elsewhere [27]. Briefly, 0.5 × 106 cells were seeded in complete RPMI 
with 100 nM PMA for 24 h, in 24-well plates. Non-adherent cells were 
then removed, and the adherent cells were washed twice with complete 
RPMI. Then, they were incubated for additional 48 h in complete RPMI 
without PMA. THP-1 cells were incubated, or not, for 2 h with 
100 ng/mL of LPS in fresh medium for their stimulation. Afterwards, 
cells were incubated with different concentrations of LUVs (0, 0.01, 
0.02, 0.05, 0.10 and 0.20 mM) or positive controls, namely dexameth-
asone (10 µM) or celecoxib (10 µM). After 22 h of incubation, cells were 
retrieved and supernatants were collected and stored at − 80 ºC until 
further analyses. 
2.6.2. Cell metabolic activity 
The metabolic activity of the cells was evaluated using the MTS assay 
(CellTiter 96® AQueous One Solution Cell Proliferation Assay), ac-
cording to the manufacturer’s instructions. At all time-points, cells were 
incubated with a mixture of culture medium, without FBS and phenol 
red, and MTS reagent (ratio of 5:1) for 3 h at 37 ◦C in a humidified 5% 
CO2 atmosphere. The absorbance of the MTS reaction medium was then 
measured in triplicate at 490 nm in a microplate reader (Synergy HT, 
BioTek). Absorbance is directly proportional to the number of meta-
bolically active cells in culture. 
2.6.3. Cell proliferation 
Cell proliferation was assessed using the Quant-iT™ Pico Green® 
dsDNA Assay Kit, in accordance with the manufacturer’s instructions. 
Briefly, 1 mL of ultrapure water was added to the cells and then they 
were collected and stored at − 80 ºC until further analyses. Samples 
were defrosted and sonicated for 15 min, before DNA quantification. 
28.7 μL of sample or standard solution, 71.3 μL of PicoGreen solution, 
and 100 μL of Tris-EDTA buffer were mixed and incubated for 10 min at 
RT. The fluorescence intensity was measured in triplicate at excitation 
and emission wavelengths of 485 ± 20 nm and 528 ± 20 nm, respec-
tively, in a microplate reader (Synergy HT, BioTek). The DNA concen-
tration for each sample was calculated using a standard curve of DNA 
concentration (ranging from 0 to 2 µg/mL) versus fluorescence 
intensity. 
2.6.4. Total protein 
The total protein content of the cells was determined using the Micro 
BCA™ Protein Assay kit, following the manufacturer’s instructions. 
Samples were treated as described above for DNA quantification. Then, 
150 μL of sample or standard solution and 150 μL of working reagent 
were mixed and incubated for 2 h at 37 ºC. The absorbance at 562 nm 
was measured in triplicate using a microplate reader (Synergy HT, 
BioTek). The protein content for each sample was determined using a 
standard curve of albumin concentration (ranging from 0 to 40 µg/mL) 
versus absorbance. 
2.6.5. Cell morphology 
For the assessment of cell morphology, cells were observed at all 
time-points under an inverted microscope (AxioVert A1 FL LED, Zeiss), 
and optical images were acquired at magnifications of 10 and 20x. 
2.7. Anti-inflammatory activity 
The anti-inflammatory activity of the LUVs was evaluated by their 
ability to reduce the amount of pro-inflammatory cytokines and che-
mokines that are produced by LPS-stimulated THP-1 cells after 22 h of 
incubation. Dexamethasone and celecoxib were used as positive con-
trols. The quantification of IL-6, IL-1β, TNF-α, IL-23 and CCL2 in the 
culture supernatants was performed by commercially available ELISA 
kits (R&D Systems, Minneapolis, MN, USA), following the recommen-
dations of the manufacturer. Briefly, a 96-well plate was coated with the 
respective capture antibody overnight at RT. Then, the plate was washed 
and blocked with 1% bovine serum albumin in PBS for 1 h, at RT. After 
washing, 100 μL of culture supernatants or standards were added to 
each well and incubated during 2 h, at RT. The plate was then washed, 
and the respective detection antibody was added, being this mixture 
incubated for 2 h, at RT. After washing, the incubation with streptavidin 
conjugated to horseradish peroxidase was performed for 20 min, at RT. 
The plate was washed again and the substrate solution was added to 
each well for 20 min, at RT. Finally, the stop solution was added to each 
well and the absorbance was measured at 450 and 540 nm using a 
microplate reader (Synergy HT, BioTek). Readings at 450 nm were 
subtracted from readings at 540 nm for wavelength correction. The 
concentration of cytokines and chemokine for each sample was deter-
mined using a standard curve of concentration versus absorbance. 
2.8. Statistical analysis 
Data are shown as arithmetic means ± standard deviation of at least 
three independent measurements. Statistical analyses were performed 
using GraphPad Prism software v5.01 (GraphPad Software, Inc., USA). 
The statistical significance of the difference between the conditions 
assessed was analysed using the non-parametric Kruskal-Wallis test 
followed by Dunn’s multiple comparison test. Differences were consid-
ered statistically significant when p < 0.05. 
3. Results 
3.1. Characterization of LUVs 
The size, PDI and zeta potential of the liposomes produced in this 
Table 1 
Size, PDI and zeta potential of fishroesomes, DPPC LUVs and EPC LUVs.  
Formulations Size (nm) PDI Zeta Potential (mV) 
Fishroesomes 331.3 ± 76.8 0.34 ± 0.09 -27.1 ± 3.2 
DPPC LUVs 142.9 ± 12.6 0.15 ± 0.07 -2.9 ± 3.8 
EPC LUVs 143.9 ± 11.3 0.13 ± 0.07 -3.9 ± 2.5  
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work are presented in Table 1. Fishroesomes are bigger and present a 
higher heterogeneity in terms of size (higher PDI values) than the li-
posomes used as controls (DPPC and EPC LUVs). Moreover, while DPPC 
and EPC LUVs present slightly negative zeta potential values, fish-
roesomes have a stronger negative surface charge (Table 1). 
In Fig. 1A it is possible to observe that DPPC and EPC LUVs keep their 
size during the studied period (one month), while the size of the sardine 
roe-derived LUVs changed few days after their preparation. This illus-
trates the importance of using these LUVs in a short period of time after 
their production, without the need to resort to additional procedures. 
PDI values were constant throughout the experiment only for EPC LUVs, 
as illustrated in Fig. 1B. Variations in zeta potential over time were also 
obtained for fishroesomes, whereas this parameter was more constant 
for the other formulations (Fig. 1C). 
In Fig. 1D it is possible to analyse the fishroesomes. The small LUVs 
seem having a circular cross-section, but the larger ones seem to have 
some fluidity in its shape having oval cross-sections. They also present a 
heterogeneous distribution in terms of size, which corroborates DLS 
measurements. 
3.2. Antioxidant activity 
3.2.1. ROO• scavenging assay 
In the present work, the antioxidant capacity of the tested formula-
tions against ROO•, generated by the thermo-decomposition of AAPH at 
37 ºC, was evaluated using fluorescein and TMA-DPH. In the presence of 
an antioxidant, the radicals are scavenged and the decay of the probe 
fluorescence is delayed. The assays performed with the hydrophilic 
probe demonstrated that increasing concentrations of the liposomes 
(considering their content in phosphatidylcholine) and the reference 
antioxidant, trolox, retarded the decay of the fluorescein fluorescence 
(Fig. 2A-D). Fig. 2E presents the results determined by Eq. (1). It is 
possible to observe that fishroesomes presented a higher antioxidant 
activity than trolox as well as EPC and DPPC liposomes, as demonstrated 
in Fig. 2A-D. Indeed, DPPC LUVs did not present a quantifiable 
antioxidant activity against these radicals, while EPC LUVs were much 
less active than sardine roe-derived LUVs for all the tested concentra-
tions (Fig. 2). Table 2 shows the IC50 values (calculated as the concen-
tration of each compound required to obtain 50% in Eq. (1)) of the 
scavenger activity of the tested compounds against ROO•. Fishroesomes 
presented the lowest IC50 value, and thus this formulation had a higher 
antioxidant activity even than trolox, because a lower LUVs concen-
tration is needed to obtain equivalent antioxidant capacity. Conse-
quently, Fig. 2 demonstrates that ROO• are efficiently scavenged by 
fishroesomes. 
In the TMA-DPH assays, liposomes were also able to prevent the 
oxidation of the probe in a concentration-dependent manner (Fig. 3). 
Increasing the concentration of all formulations avoided the immediate 
decay of the probe fluorescence. Fishroesomes were much more active 
against ROO• than the other LUVs formulations. These results show that 
sardine roe-derived LUVs act as potent ROO• scavenger even when the 
active part of the fluorescence probe is in the hydrophobic region of the 
lipid bilayer. 
3.2.2. •OH scavenging assay 
The antioxidant efficiency of the liposomes as scavengers of •OH, 
generated by the Fenton reaction, was also assessed by their ability to 
avoid fluorescein and TMA-DPH oxidation and, consequently, fluores-
cence decay. The antioxidant activity of the tested formulations was also 
expressed as IC50 values calculated using Eq. (1) (Table 2). 
Fig. 4A shows that increasing concentrations of the fishroesomes 
resulted in an enhanced delay in the fluorescence decrease of fluores-
cein. Consequently, these liposomes presented antioxidant activity 
against •OH in a concentration-dependent manner. A similar conclusion 
was obtained for the reference antioxidant trolox (Fig. 4D). Conversely, 
DPPC and EPC LUVs did not present ability to scavenge these radicals 
(Fig. 4B and C). In Fig. 4E and Table 2 is possible to observe that the 
scavenging activity of fishroesomes in the presence of •OH is comparable 
to that observed for trolox. 
All LUVs formulations prevented the oxidation of TMA-DPH induced 
Fig. 1. Size (A), PDI (B) and zeta potential (C) of fishroesomes, DPPC LUVs and EPC LUVs suspensions in PBS, stored at 4 ºC for one month. STEM micrograph (D) of 
the fishroesomes. Scale bar = 100 nm. 
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by •OH in a dose-dependent manner (Fig. 5). Fishroesomes had a more 
potent effect against these radicals, since the decay of fluorescence in-
tensity was more retarded compared to the same tested PC concentra-
tions of the other LUVs formulations. 
3.2.3. NO• scavenging activity 
NO• neutralization by LUVs formulations was evaluated using SNP, 
which spontaneously generates NO•. When antioxidants are present, 
they compete with oxygen leading to reduced production of nitrite ions 
and, thus, lower formation of the coloured product is also observed. 
The antioxidant activity of the tested formulations and gallic acid 
(used as reference antioxidant) against NO• was expressed as IC25 values 
using Eq. (2). Fig. 6 and Table 2 demonstrate that the antioxidant effi-
ciency of fishroesomes was smaller than that observed for the reference 
antioxidant, since a higher concentration of these liposomes was 
necessary to obtain the same effect. Moreover, DPPC and EPC LUVs were 
Fig. 2. Relative fluorescence intensity of fluorescein in the presence of ROO• and different concentrations of fishroesomes (A; 0, 0.5, 1.0, 2.5, 5.0, 12.5, 25.0 and 
50.0 µM), DPPC LUVs (B; 0, 0.5, 1.0, 2.5, 5.0, 12.5, 25.0 and 50.0 µM), EPC LUVs (C; 0, 0.5, 1.0, 2.5, 5.0, 12.5, 25.0 and 50.0 µM) or trolox (D; 0, 2.5, 5.0, 10.0, 15.0 
and 20.0 µM), at 37 ºC. Scavenging activity of the tested compounds against ROO• using Eq. (1) versus their concentration (E). 
Table 2 
Scavenging activities of the tested compounds and respective reference antiox-
idants against ROO•, •OH, NO• and O2•-.   
ROO• •OH NO• O2•- 
Tested 
compounds 
IC50 (µM) IC25 (µM) 
Fishroesomes 0.81 ± 0.64 10.35 ± 8.27 83.57 ± 28.15 n.r. 
DPPC LUVs n.r. n.r. n.r. n.r. 
EPC LUVs 15.06 ± 3.21 n.r. n.r. n.r. 
Trolox 1.66 ± 0.22 11.47 ± 8.60   
Gallic acid   7.80 ± 0.31  
Ascorbic acid    13.67 ± 2.44 
n.r. — not reached. 
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not able to achieve 25% of NO• scavenging activity (Fig. 6). 
3.2.4. O2•- scavenging assay 
In the O2•- scavenging assay, radicals were produced in the NADH- 
PMS reaction. When antioxidants are present, they neutralize the radi-
cals leading to a reduced production of the coloured product. The LUVs 
formulations studied did not present ability to reduce the coloured 
product and, consequently, they show no activity as scavengers of O2•- 
(Table 2). 
3.3. Biological assays 
Different cell biology protocols were performed to evaluate the effect 
of fishroesomes on the metabolic activity, proliferation, protein syn-
thesis and morphology of L929 cells and macrophages. 
MTS assay results demonstrated that fishroesomes are cytocompat-
ible for concentrations until 0.25 mM in the presence of L929 cells, at all 
time-points tested (Fig. 7A). However, L929 cell proliferation signifi-
cantly decreased for LUVs (PC) concentration equal or higher than 
0.25 mM when compared to the control, in the time-points tested 
(Fig. 7B). Regarding the protein concentration, L929 cells were able to 
synthesize more protein in the presence of 0.06 and 0.12 mM of fish-
roesomes, at 24 and 72 h, respectively (Fig. 7C). The opposite was 
observed for the concentrations 0.25, 0.50 and 1.00 mM. The evaluation 
of the cell morphology corroborated these results. As it is possible to 
observe in Fig. 7D-F, only the highest tested concentrations (0.50 and 
1.00 mM) altered the morphology of L929 cells. 
Considering the effect of fishroesomes on the biological performance 
of the L929 cells, lower concentrations were tested in the in vitro assays 
performed with non- or LPS-stimulated macrophages. Indeed, a pre-
liminary assay was performed to assess the metabolic activity and 
morphology of non-stimulated macrophages in the presence of LUVs 
formulations. This assay demonstrated that only the highest tested 
concentration of fishroesomes affected the metabolic activity of the non- 
stimulated THP-1 cells (Fig. 8A). Conversely, the effect of DPPC LUVs 
was comparable to the control for all tested concentrations (Fig. 8B). The 
morphology of these cells was not altered by any formulation (Fig. 8C- 
F). 
Similarly, for LPS-stimulated macrophages, only fishroesomes at a 
concentration equal to 0.20 mM had a negative impact, reducing the 
metabolic activity of cells by about 50%, and their amount (DNA con-
centration) and protein synthesis by 40% (Fig. 9A1, B1 and C1, 
respectively). The morphology of LPS-stimulated macrophages was also 
not significantly altered by these LUVs (Fig. 9E-G). The effect of DPPC 
LUVs on macrophages behaviour presented again a good cytocompati-
bility at all tested concentrations (Fig. 9A2, B2, C2, H and I). 
3.4. Anti-inflammatory activity 
LPS-stimulated THP-1 cells were used to assess the anti- 
inflammatory activity of the liposomes. It is possible to observe in  
Fig. 10 that non-stimulated macrophages do not produce pro- 
inflammatory mediators. Importantly, this figure also demonstrates 
that fishroesomes cause a decrease in the production of all the proteins 
assessed. The decrease on the amount of IL-1β and CCL2 was dose- 
dependent. For IL-6, the greatest decrease in its content was observed 
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Fig. 3. Relative fluorescence intensity of TMA-DPH in the presence of ROO• and different concentrations of fishroesomes (A; 0.05, 0.10, 0.18, 0.25, 0.50 and 
1.00 mM), DPPC LUVs (B; 0.05, 0.10, 0.18, 0.25, 0.50 and 1.00 mM) or EPC LUVs (C; 0.05, 0.10, 0.18, 0.25, 0.50 and 1.00 mM), at 37 ºC. 
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for the highest tested concentrations of fishroesomes. Moreover, a high 
decrease in the amounts of IL-6 (60%), IL-1β (68%), IL-23 (47%) and 
CCL2 (46%) in the presence of 100 μM fishroesomes is observed. The 
effect of these liposomes at 12.5 μM on the levels of IL-6 (Fig. 10A) and 
CCL-2 (Fig. 10E) was similar and superior than that observed for cele-
coxib, respectively. DPPC LUVs do not affect significantly the amount of 
cytokines or chemokine. These data suggest that fishroesomes exert a 
significant anti-inflammatory effect by decreasing the production of 
some pro-inflammatory cytokines and chemokine. 
4. Discussion 
The main objective of this work was the preparation of LUVs from 
sardine roe lipidic extracts, designated as fishroesomes. Their physico-
chemical characterization, cytocompatibility assessment, as well as their 
antioxidant and anti-inflammatory activities evaluation were performed 
to demonstrate the potential of these new drug delivery devices. 
LUVs prepared from sardine roe phospholipids presented a higher 
size (331.3 ± 76.8 nm) and heterogeneity (PDI of 0.34 ± 0.09) than li-
posomes made of DPPC and EPC (Table 1). Despite the same method was 
used to prepare the three liposomal formulations, fishroesomes pre-
sented a higher size compared to EPC and DPPC LUVs. However, it is 
well known that the lipidic composition (e.g., presence and percentage 
of sterols) affects several properties of the liposomes, such as stability, 
curvature of the bilayer, phase-transition temperature and formation of 
lipid domains. Moreover, over time, LUVs can suffer modifications in 
their leaflet compositions to decrease the curvature energy to a mini-
mum. This is probably due to a directional "flip-flop" movement of the 
phospholipid molecules, since the starting number of phospholipids in 
the outer leaflet is greater than in the inner leaflet [28]. Therefore, as in 
this work a mixture of natural lipids was used to produce fishroesomes, 
after extrusion, they can reorganize to achieve a high stability, and 
consequently, a higher size was obtained. Zeta potential measurements 
also demonstrated a significant difference between the liposomes with 
different compositions. The slight negative zeta potential values 
observed for DPPC and EPC LUVs are in agreement with those reported 
elsewhere [29,30]. Conversely, fishroesomes presented a more negative 
surface charge (− 27.1 ± 3.2 mV), possibly due to the presence of 
phospholipids with anionic polar head groups, such as phosphatidic 
acid, phosphatidylserine and phosphatidylinositol [31]. Indeed, sardine 
roe-derived LUVs present a higher variety of lipids, mainly when 
compared to DPPC LUVs, which have a homogeneous composition. Lipid 
composition and also the presence of other fat-soluble biomolecules in 
the fishroesomes can explain the differences observed in these 
Fig. 4. Relative fluorescence intensity of fluorescein in the presence of •OH and different concentrations of fishroesomes (A; 0, 0.5, 1.0, 2.5, 5.0, 12.5, 25.0 and 
50.0 µM), DPPC LUVs (B; 0, 0.5, 1.0, 2.5, 5.0, 12.5, 25.0 and 50.0 µM), EPC LUVs (C; 0, 0.5, 1.0, 2.5, 5.0, 12.5, 25.0 and 50.0 µM) or trolox (D; 0, 2.5, 5.0, 10.0, 15.0 
and 20.0 µM), at 37 ºC. Scavenging activity of the tested compounds against •OH using Eq. (1) versus their concentration (E). 
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Fig. 5. Relative fluorescence intensity of TMA-DPH in the presence of •OH and different concentrations of fishroesomes (A; 0.05, 0.10, 0.18, 0.25, 0.50 and 
1.00 mM), DPPC LUVs (B; 0.05, 0.10, 0.18, 0.25, 0.50 and 1.00 mM) or EPC LUVs (C; 0.05, 0.10, 0.18, 0.25, 0.50 and 1.00 mM), at 37 ºC. 










































Fig. 6. Scavenging activity of the tested compounds against NO• using Eq. (2) versus their concentration.  
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properties. 
The stability is also one of the most important features when envi-
sioning the use of those liposomes after a storage period. The stability of 
liposome suspensions is influenced by their physical, chemical and 
biological stability and also by the extent of electrical and/or steric 
repulsive forces operating between them (zeta potential) [32]. During 
the storage of the liposomes, phospholipid membranes may degrade, 
aggregate and fuse, which, in turn, can lead to changes in the mean size 
and size distribution towards higher values. The stability of the lipo-
somes is evaluated by the changes of these physical properties. The 
values of size, PDI and zeta potential for fishroesomes are not constant, 
while for DPPC and EPC LUVs they did not change significantly during 
the period considered, with the exception of the PDI values of DPPC 
LUVs from day 4 (Fig. 1A-C). Puskás and Csempesz reported that both 
the mean size and the PDI of the DPPC liposomes increased after one 
week of storage at 25 ºC [32]. Although the stability of fishroesomes was 
lower than that of the other formulations, this can be improved by 
adding cholesterol, since it has been reported that this molecule can 
enhance membrane stability [18]. Moreover, these liposomes can be 
stored in the lyophilized form and reconstituted immediately before use. 
The assessment of the antioxidant activity of sardine roe-derived 
LUVs was carried out against different ROS (ROO•, •OH and O2•-) and 
RNS (NO•). At low levels, ROS and RNS contribute to cell signalling, 
mitochondrial respiration and biogenesis, but at high levels, they can 
damage essential biomolecules, leading to, for instance, lipid peroxi-
dation, protein oxidation and DNA strand scission [33]. These 
Fig. 7. Effect of fishroesomes and 10% DMSO (positive control for cell death) on the L929 cells metabolic activity (A), DNA concentration (B) and total protein 
content (C). Cells were or not (control; dashed line corresponding to 100%) incubated with different concentrations of fishroesomes (0.06, 0.12, 0.25, 0.50 and 
1.00 mM) or 10% DMSO, for 24, 48 and 72 h. *p < 0.05 versus control; **p < 0.01 versus control; ***p < 0.001 versus control. Optical images of L929 cells 
incubated with fishroesomes at 0 (1), 0.25 (2), 0.50 (3) and 1.00 mM (4) or 10% DMSO (5) for 24 (D), 48 (E) and 72 h (F). Scale bar = 50 µM. 
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modifications impair different physiological functions and lead to the 
development of several disorders, including inflammatory diseases. The 
protection of organisms against the negative effects of reactive species is 
therefore extremely important. Several endogenous antioxidants can 
impair the negative effects of the reactive species, but they may be 
decreased during oxidative stress and inflammation. In this case, exog-
enous antioxidants with effective scavenging action against reactive 
species have an added importance. Consequently, there is a growing 
need to study the antioxidant ability of different compounds, envision-
ing their application in the prevention or therapy of these disorders. 
The antioxidant capacity of the tested formulations against ROO•
and •OH was evaluated in the presence of probes with different solu-
bilities and, consequently, they have stronger interactions with different 
compartments of the liposomes. Fluorescein is in the aqueous media 
surrounding the liposomes, while the active part of the TMA-DPH is 
located in the LUVs hydrophobic region, and thus the interaction be-
tween this probe and free radicals occurs within the lipid bilayer [34]. 
Moreover, TMA-DPH is almost nonfluorescent in the aqueous media 
[35]. Despite ROO• and •OH being produced in the aqueous phase, they 
are able to diffuse easily through the bilayer and react with hydrocarbon 
chains promoting their oxidation [36]. The results obtained in this study 
demonstrate that ROO• and •OH can be efficiently scavenged by fish-
roesomes, regardless of the location of the fluorescent probe. Indeed, the 
existence of a plateau in the fluorescence assays (Figs. 2–5) indicates 
that the tested formulations react much more rapidly with the radicals 
than the probe [23]. Once the antioxidant compounds are consumed in 
the reaction, the decay of the signal is similar to that of the blank. 
In the fluorescein assays, the effect of fishroesomes against ROO• and 
•OH was superior (Fig. 2), or similar (Fig. 4), to that observed for trolox, 
respectively. Besides trolox, DPPC and EPC LUVs were also used as 
controls, since these synthetic and natural phospholipids, respectively, 
have been extensively used in liposomes preparation. DPPC LUVs were 
used as negative control for the assessment of LUVs antioxidant and anti- 
inflammatory properties, because it was previously shown that DPPC 
does not have antioxidant effect [37]. EPC LUVs were used as positive 
control due to their improved antioxidant activity, when compared with 
other phospholipids [2,38]. However, in this work, DPPC and EPC LUVs 
presented less antioxidant efficiency against ROO• than fishroesomes 
and trolox, and they do not act as •OH scavengers. 
Regarding TMA-DPH assays, sardine roe-derived LUVs were more 
potent as ROO• (Fig. 3) and •OH (Fig. 5) scavengers than DPPC and EPC 
LUVs. Unexpectedly, the effect of DPPC LUVs as ROO• scavenger was 
similar to that observed for EPC LUVs. This result may be explained by 
the fatty acids composition of DPPC LUVs. The presence of saturated 
fatty acids decreases the membrane fluidity of liposomes, in comparison 
with unsaturated fatty acids [39]. Consequently, radicals may have 
limited access to initiate peroxidation along the hydrocarbon chains of 
the DPPC LUVs. In addition, the chain reaction of lipid peroxidation is 
unable to propagate efficiently [36]. 
The present study demonstrated that fishroesomes can act as scav-
engers of NO•, although they are less potent than the reference antiox-
idant used, gallic acid (Fig. 6). Some studies showed that lipidic extracts 
from various tissues of seafood species reduced significantly the pro-
duction of NO• and the expression of the inducible nitric oxide synthase 
(iNOS) gene, an isoform of the enzyme that synthesizes NO• [40–42]. 
This effect can be caused by the presence of eicosapentaenoic acid (EPA) 
and docosahexaenoic acid (DHA), as suggested by Allam-Ndoul and 
co-authors [43]. Moreover, DHA-loaded liposomes inhibited the acti-
vation of nuclear factor kappa B, which plays a crucial role in inducing 
NO• production via iNOS [40]. Additionally, herein it was shown that 
fishroesomes, as well as DPPC and EPC LUVs, do not exhibit O2•- scav-
enging activity under the experimental conditions tested (Table 2). 
The antioxidant activity of fishroesomes can be due to the presence, 
as just referred, of ω3 PUFA, but also of others lipophilic antioxidants, 
such as tocopherols (e.g., vitamin E), carotenoids (e.g., β-carotene, 
astaxanthin, canthaxanthin), ubiquinones (e.g., coenzyme Q10), lipoic 
acid and phospholipids [2]. Indeed, coenzyme Q10 and vitamin E were 
identified in the muscle tissue of the sardine species used in this work 
[44]. The lipophilic antioxidants mentioned can have different mecha-
nisms of action [2]. Tocopherols, carotenoids and ubiquinones can 
inhibit the propagation of free radical reactions, such as lipid peroxi-
dation. Tocopherols, carotenoids and phospholipids can reinforce the 
activity of other antioxidants. Phospholipids can also act as metal 
scavengers, inhibiting metals to catalyse the production of free radicals. 
In addition, carotenoids can inactivate singlet oxygen, and it has been 
proposed that ubiquinones and phospholipids are able to recycle other 
antioxidants, such as vitamin E. All the antioxidants present in the 
fishroesomes may exert a synergistic effect in the scavenging of the 
radicals. There are studies that report an effective antioxidant activity of 
phospholipids in synergy with α-tocopherol extracted from different 
marine species, including sardine [37,45]. 
Since both ROS and RNS are produced by immune cells, such as 
Fig. 8. Effect of fishroesomes (A) and DPPC LUVs (B) on the metabolic activity of non-stimulated macrophages. Cells were or not (control; dashed line corresponding 
to 100%) incubated with different concentrations of LUVs (0.01, 0.02, 0.05, 0.10 and 0.20 mM), for 24 h. *p < 0.05 versus control; **p < 0.01 versus control; 
***p < 0.001 versus control. Optical images of non-stimulated macrophages incubated with fishroesomes at 0 (C), 0.10 (D) and 0.20 mM (E) or DPPC LUVs at 
0.01 mM (F), for 24 h. Scale bar = 50 µM. 
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activated macrophages, during the inflammatory process [46], they are 
considered reliable markers for the screening of new anti-inflammatory 
treatments [42]. The observed ability to scavenge these inflammatory 
mediators may also contribute to the anti-inflammatory effects of 
fishroesomes. 
The effect of the produced LUVs on the biological performance of 
L929 and THP-1 cells stimulated, or not, with LPS was concentration- 
dependent (Figs. 7–9). Some studies evaluated the cytocompatibility 
of lipidic extracts and/or liposomes composed of phospholipids obtained 
from fish or fish oil. Similarly to what was observed in the present work, 
these authors describe that their formulations do not impair the per-
formance of the cells or have slight negative effects. For instance, salmon 
liposomes did not present any toxic effect on the neuronal metabolic 
activity [47]. Another study demonstrated that liposomes encapsulating 
DHA extracted from fish oil reduced the viability of LPS-stimulated 
THP-1 cells by about 30%, at the highest tested concentration 
(0.5 mM of total lipid) [40]. Considering non-stimulated RAW264.7 
macrophages, lipids extracted from Arctoscopus japoniscus eggs did not 
Fig. 9. Effect of fishroesomes (1) and DPPC 
LUVs (2) on the LPS-stimulated macrophages 
metabolic activity (A), DNA concentration (B) 
and total protein content (C). Cells were or not 
(control; dashed line corresponding to 100%) 
incubated with different concentrations of LUVs 
(0.01, 0.02, 0.05, 0.10 and 0.20 mM), for 22 h. 
*p < 0.05 versus control; **p < 0.01 versus 
control; ***p < 0.001 versus control. Optical 
images of LPS-stimulated macrophages incu-
bated with fishroesomes at 0 (D), 0.05 (E), 0.10 
(F) and 0.20 mM (G) or DPPC LUVs at 0.01 (H) 
and 0.20 mM (I), for 22 h. Scale bar = 50 µM.   
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decrease their proliferation (2% lipids was the highest tested concen-
tration) [41]. Finally, none of the lipid extracts from common Australian 
seafood by-products at 50 µg/mL reduced the cell viability of 3T3-ccl-92 
fibroblasts and non-stimulated RAW 264.7 macrophages [42]. The 
highest concentrations of fishroesomes negatively affected the cell 
behaviour, possibly due to the presence of free fatty acids, which have 
toxic effects on mammalian cells [48]. However, this can be improved 
by submitting the lipid extracts to a chemical extraction before sardine 
roe-derived LUVs preparation [16]. 
The anti-inflammatory effects of sardine roe-derived LUVs and DPPC 
LUVs were evaluated using LPS-stimulated macrophages. Macrophages 
are very sensitive to LPS, expressing many inflammatory cytokines (e.g., 
IL-1β, IL-6, TNF-α and IL-23) and chemokines (e.g., CCL2) [11,21]. The 
pro-inflammatory cytokines and chemokines selected in this work play 
important roles in the inflammatory process, including the initiation of 
the inflammatory response and the recruitment and activation of im-
mune cells to the site of injury. Fishroesomes reduced LPS-induced cy-
tokines production in a dose-dependent manner (Fig. 10). The 
anti-inflammatory effect of these liposomal formulations was compared 
with that of clinically used anti-inflammatory drugs, namely dexa-
methasone and celecoxib. As Fig. 10 illustrates, the treatment of 
LPS-stimulated macrophages with the highest tested concentration of 
fishroesomes resulted in a similar decrease in IL-1β and TNF-α levels 
compared to dexamethasone. Moreover, the inhibitory effects of these 
LUVs, at all tested concentrations, were similar or superior than those 
observed for celecoxib. This effect may be related to the high levels of ω3 
Fig. 10. Effect of fishroesomes, DPPC LUVs, 
dexamethasone and celecoxib on the produc-
tion of IL-6 (A), IL-1β (B), TNF-α (C), IL-23 (D) 
and CCL2 (E) by THP-1 cells stimulated, or not 
(NS), with LPS. Cells were incubated with 
different concentrations of LUVs (12.5, 25.0, 
50.0 and 100.0 µM), dexamethasone (10 µM) or 
celecoxib (10 µM), for 22 h. The dashed line 
represents the nontreated condition (0 µM; LPS 
positive control) for each assay. *p < 0.05 
versus control; **p < 0.01 versus control; 
***p < 0.001 versus control; # p < 0.05 versus 
dexamethasone; & p < 0.05 versus celecoxib.   
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PUFAs, namely DHA and EPA, present in the lipidic extracts of sardine 
roe, previously analysed by our group using a GC/MS technique [16]. 
Indeed, these fatty acids are well known for their anti-inflammatory 
properties. Several mechanisms may explain these actions. DHA and 
EPA suppress leukocytes and macrophages infiltration, inhibit adhesion 
molecule expression and leukocyte-endothelial adhesive interactions, 
reduce the production of eicosanoids (e.g., prostaglandins and leuko-
trienes) from arachidonic acid and inflammatory cytokines (e.g., TNF-α 
and IL-6), modify T cell reactivity, and increase the production of 
anti-inflammatory endocannabinoids and inflammation resolving me-
diators (e.g., resolvins, protectins, and maresins) [5]. Moreover, these 
fatty acids effectively inhibit the expression of several cytokines by 
LPS-stimulated macrophages. For instance, DHA-loaded liposomes 
inhibited the production of TNF-α and CCL2 in LPS-stimulated THP-1 
cells [40]. The ability of DHA to inhibit the expression of IL-1β, IL-6 and 
TNF-α genes in LPS-stimulated THP-1 cells was also already reported 
[49]. Additionally, A. japoniscus egg lipids suppressed the expression of 
these genes by LPS-stimulated RAW264.7 macrophages [41]. Lipidic 
extracts from commonly consumed Australian seafood also reduced the 
levels of TNF-α in this murine macrophage cell line [42]. 
Importantly, the antioxidant and anti-inflammatory activities of 
fishroesomes can also be attributed to the fact that these fatty acids are 
in the phospholipids, instead of being free, which will protect them 
against lipid peroxidation, increasing their oxidative stability [50]. The 
presence of vitamin E may also contribute to this. Additionally, it has 
been reported that liposomes formed by marine phospholipids have 
advantageous features, including better oxidative stability, higher 
bioavailability, and superior fluidity when compared to other types of 
liposomes [51]. 
Finally, it is important to emphasize that fishroesomes have 
remarkable antioxidant and anti-inflammatory effects at concentrations 
of phosphatidylcholine in which they are not toxic for the two types of 
cells studied. 
5. Conclusions 
The search for natural origin compounds with antioxidant and anti- 
inflammatory properties, low toxicity and low cost is of great interest for 
the development of new formulations for the treatment of inflammatory 
diseases. In the present work, liposomes were produced from the lipidic 
extracts derived from sardine (Sardina pilchardus) roe, in the past 
considered a by-product of the fish industry. Fishroesomes demon-
strated cytocompatibility for concentrations in which they exhibit 
antioxidant and anti-inflammatory activities, and frequently with a 
higher efficacy than the positive controls. Consequently, the developed 
sardine roe-derived LUVs may be considered as a valid alternative for 
the treatment or as a carrier for the treatment of inflammatory condi-
tions, such as osteoarthritis and rheumatoid arthritis. 
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